Addressing Unmet Needs in Cancer Care with

Addressing Unmet Needs in Cancer Care with

About Jay PharmaNews and Insights

Jay Pharma has identified and is advancing compelling new growth opportunities within the cannabis sector together with our partner institutions, including Tikun Olam, one of the leading, research-focused medical cannabis companies globally. To date, the use of cannabis in cancer management has been relegated to symptoms management, but an emerging body of research suggests that cannabidiol (CBD), a primary cannabis plant constituent, may have a therapeutic, anti-tumor effect on certain types of cancers.

Explore the Science of CBDCBD Combination Therapies

OTC Program

Cancer and its treatment often cause side effects – we believe that improving quality of life and supporting patients and their families is a critical part of cancer care. Jay Pharma is developing a differentiated line of over-the-counter (OTC) products to improve the lives of persons suffering from cancer.

Learn More

Pipeline

Jay Pharma is advancing a pipeline of novel combination therapies as an adjunct to standard of care cancer treatments, with plans to initiate exploratory clinical studies in conditions that include glioblastoma multiforme, triple-negative breast cancer, acute myeloid leukemia, and pancreatic cancer.

Learn More